When a pilot proteomic study was performed in brain samples of patients with AD and normal control subjects to identify APP interactors, 21 proteins were identified which could be grouped into five functional classes: molecular chaperones, cytoskeletal and structural proteins, adaptors, enzymes, and proteins involved in trafficking. Here, APP is linked to Alzheimer disease.